id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1976-N-0027-0019,FDA,FDA-1976-N-0027,Guidance,Supporting & Related Material,GDL-Guidance,2004-12-06T05:00:00Z,2004,12,,,2015-12-11T16:49:39Z,,0,0,090000648051b777
FDA-1976-N-0027-0018,FDA,FDA-1976-N-0027,Guidance,Supporting & Related Material,Guidance,2004-12-06T05:00:00Z,2004,12,,,2015-12-11T16:49:49Z,,0,0,090000648051b776
FDA-1976-N-0027-0020,FDA,FDA-1976-N-0027,Background Material,Supporting & Related Material,BKG-Background Material,2004-12-06T05:00:00Z,2004,12,,,2008-05-30T22:57:02Z,,0,0,090000648051b778
FDA-1976-N-0027-0017,FDA,FDA-1976-N-0027,Notice of Proposed Rulemaking re OTC Nasal Decongestant Drug Products,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2004-11-02T05:00:00Z,2004,11,2004-11-01T05:00:00Z,2005-02-01T04:59:59Z,2015-10-29T20:31:58Z,,0,0,090000648051b771
FDA-1976-N-0027-0010,FDA,FDA-1976-N-0027,Memorandum from FDA/ Public Health Advisory re Safety of Phenylpropanolamine,Other,Memorandum,2004-09-17T04:00:00Z,2004,9,,,2015-10-29T19:59:35Z,,0,0,090000648051b769